We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Guidance Helps IVD-Makers Expedite CLIA Categorization
New Guidance Helps IVD-Makers Expedite CLIA Categorization
June 11, 2008
In vitro diagnostic (IVD) manufacturers can help expedite U.S. Food and Drug Administration (FDA) categorization of their tests under the Clinical Laboratory Improvement Amendments (CLIA) by following a new guidance.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor